Literature DB >> 15964796

Functional analysis of the roles of posttranslational modifications at the p53 C terminus in regulating p53 stability and activity.

Lijin Feng1, Tongxiang Lin, Hiroaki Uranishi, Wei Gu, Yang Xu.   

Abstract

Posttranslational modification of the tumor suppressor p53 plays important roles in regulating its stability and activity. Six lysine residues at the p53 C terminus can be posttranslationally modified by various mechanisms, including acetylation, ubiquitination, neddylation, methylation, and sumoylation. Previous cell line transfection studies show that ubiquitination of these lysine residues is required for ubiquitin-dependent degradation of p53. In addition, biochemical and cell line studies suggested that p53 acetylation at the C terminus might stabilize p53 and activate its transcriptional activities. To investigate the physiological functional outcome of these C-terminal modifications in regulating p53 stability and activity, we introduced missense mutations (lysine to arginine) at the six lysine residues (K6R) into the endogenous p53 gene in mouse embryonic stem (ES) cells. The K6R mutation prevents all posttranslational modifications at these sites but conserves the structure of p53. In contrast to conclusions of previous studies, analysis of p53 stability in K6R ES cells, mouse embryonic fibroblasts, and thymocytes showed normal p53 stabilization in K6R cells both before and after DNA damage, indicating that ubiquitination of these lysine residues is not required for efficient p53 degradation. However, p53-dependent gene expression was impaired in K6R ES cells and thymocytes in a promoter-specific manner after DNA damage, indicating that the net outcome of the posttranslational modifications at the C terminus is to activate p53 transcriptional activities after DNA damage.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15964796      PMCID: PMC1157004          DOI: 10.1128/MCB.25.13.5389-5395.2005

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  44 in total

1.  Acetylation of p53 activates transcription through recruitment of coactivators/histone acetyltransferases.

Authors:  N A Barlev; L Liu; N H Chehab; K Mansfield; K G Harris; T D Halazonetis; S L Berger
Journal:  Mol Cell       Date:  2001-12       Impact factor: 17.970

2.  Deubiquitination of p53 by HAUSP is an important pathway for p53 stabilization.

Authors:  Muyang Li; Delin Chen; Ariel Shiloh; Jianyuan Luo; Anatoly Y Nikolaev; Jun Qin; Wei Gu
Journal:  Nature       Date:  2002-03-31       Impact factor: 49.962

Review 3.  Putting the stress on senescence.

Authors:  M Serrano; M A Blasco
Journal:  Curr Opin Cell Biol       Date:  2001-12       Impact factor: 8.382

4.  Essential roles of the kappa light chain intronic enhancer and 3' enhancer in kappa rearrangement and demethylation.

Authors:  Matthew Inlay; Frederick W Alt; David Baltimore; Yang Xu
Journal:  Nat Immunol       Date:  2002-04-22       Impact factor: 25.606

5.  Acetylation of p53 inhibits its ubiquitination by Mdm2.

Authors:  Muyang Li; Jianyuan Luo; Christopher L Brooks; Wei Gu
Journal:  J Biol Chem       Date:  2002-11-05       Impact factor: 5.157

6.  Pirh2, a p53-induced ubiquitin-protein ligase, promotes p53 degradation.

Authors:  Roger P Leng; Yunping Lin; Weili Ma; Hong Wu; Benedicte Lemmers; Stephen Chung; John M Parant; Guillermina Lozano; Razqallah Hakem; Samuel Benchimol
Journal:  Cell       Date:  2003-03-21       Impact factor: 41.582

Review 7.  Live or let die: the cell's response to p53.

Authors:  Karen H Vousden; Xin Lu
Journal:  Nat Rev Cancer       Date:  2002-08       Impact factor: 60.716

Review 8.  Ubiquitination, phosphorylation and acetylation: the molecular basis for p53 regulation.

Authors:  Christopher L Brooks; Wei Gu
Journal:  Curr Opin Cell Biol       Date:  2003-04       Impact factor: 8.382

9.  Mutation of mouse p53 Ser23 and the response to DNA damage.

Authors:  Zhiqun Wu; John Earle; Shin'ichi Saito; Carl W Anderson; Ettore Appella; Yang Xu
Journal:  Mol Cell Biol       Date:  2002-04       Impact factor: 4.272

10.  p53 heterozygosity alters the mRNA expression of p53 target genes in the bone marrow in response to inhaled benzene.

Authors:  Scott E Boley; Victoria A Wong; John E French; Leslie Recio
Journal:  Toxicol Sci       Date:  2002-04       Impact factor: 4.849

View more
  114 in total

1.  p53 basic C terminus regulates p53 functions through DNA binding modulation of subset of target genes.

Authors:  Pierre-Jacques Hamard; Dana J Lukin; James J Manfredi
Journal:  J Biol Chem       Date:  2012-04-18       Impact factor: 5.157

Review 2.  Posttranslational modification of p53: cooperative integrators of function.

Authors:  David W Meek; Carl W Anderson
Journal:  Cold Spring Harb Perspect Biol       Date:  2009-10-28       Impact factor: 10.005

3.  Restoration of DNA-binding and growth-suppressive activity of mutant forms of p53 via a PCAF-mediated acetylation pathway.

Authors:  Ricardo E Perez; Chad D Knights; Geetaram Sahu; Jason Catania; Vamsi K Kolukula; Daniel Stoler; Adolf Graessmann; Vasily Ogryzko; Michael Pishvaian; Christopher Albanese; Maria Laura Avantaggiati
Journal:  J Cell Physiol       Date:  2010-11       Impact factor: 6.384

Review 4.  Making sense of ubiquitin ligases that regulate p53.

Authors:  Abhinav K Jain; Michelle Craig Barton
Journal:  Cancer Biol Ther       Date:  2010-10-01       Impact factor: 4.742

Review 5.  The p53 orchestra: Mdm2 and Mdmx set the tone.

Authors:  Mark Wade; Yunyuan V Wang; Geoffrey M Wahl
Journal:  Trends Cell Biol       Date:  2010-02-19       Impact factor: 20.808

6.  Acetylation of mouse p53 at lysine 317 negatively regulates p53 apoptotic activities after DNA damage.

Authors:  Connie Chao; Zhiqun Wu; Sharlyn J Mazur; Helena Borges; Matteo Rossi; Tongxiang Lin; Jean Y J Wang; Carl W Anderson; Ettore Appella; Yang Xu
Journal:  Mol Cell Biol       Date:  2006-09       Impact factor: 4.272

Review 7.  The Tail That Wags the Dog: How the Disordered C-Terminal Domain Controls the Transcriptional Activities of the p53 Tumor-Suppressor Protein.

Authors:  Oleg Laptenko; David R Tong; James Manfredi; Carol Prives
Journal:  Trends Biochem Sci       Date:  2016-09-23       Impact factor: 13.807

8.  Recognition of RNA by the p53 tumor suppressor protein in the yeast three-hybrid system.

Authors:  Kasandra J-L Riley; Laura A Cassiday; Akash Kumar; L James Maher
Journal:  RNA       Date:  2006-04       Impact factor: 4.942

Review 9.  Targeting Mdm2 and Mdmx in cancer therapy: better living through medicinal chemistry?

Authors:  Mark Wade; Geoffrey M Wahl
Journal:  Mol Cancer Res       Date:  2009-01       Impact factor: 5.852

10.  De Novo Mutations Activating Germline TP53 in an Inherited Bone-Marrow-Failure Syndrome.

Authors:  Tsutomu Toki; Kenichi Yoshida; RuNan Wang; Sou Nakamura; Takanobu Maekawa; Kumiko Goi; Megumi C Katoh; Seiya Mizuno; Fumihiro Sugiyama; Rika Kanezaki; Tamayo Uechi; Yukari Nakajima; Yusuke Sato; Yusuke Okuno; Aiko Sato-Otsubo; Yusuke Shiozawa; Keisuke Kataoka; Yuichi Shiraishi; Masashi Sanada; Kenichi Chiba; Hiroko Tanaka; Kiminori Terui; Tomohiko Sato; Takuya Kamio; Hirotoshi Sakaguchi; Shouichi Ohga; Madoka Kuramitsu; Isao Hamaguchi; Akira Ohara; Hitoshi Kanno; Satoru Miyano; Seiji Kojima; Akira Ishiguro; Kanji Sugita; Naoya Kenmochi; Satoru Takahashi; Koji Eto; Seishi Ogawa; Etsuro Ito
Journal:  Am J Hum Genet       Date:  2018-08-23       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.